The therapeutic effect of OK-432-combined adoptive immunotherapy against liver metastases from gastric or colorectal cancers
Biotherapy · 1993
DOI: 10.1007/bf01877385 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotherapy, 1993. Verfasst von K Satoh und 8 weiteren Autor:innen. Beteiligte Einrichtung: First Department of Surgery, Faculty of Medicine, Kyoto University, Japan. Hauptthemen laut MEDLINE: Immunotherapy, Adoptive. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- First Department of Surgery, Faculty of Medicine, Kyoto University, Japan.
Zitieren
APA
Satoh, K., Kan, N., Okino, T., Mise, K., Yamasaki, S., Harada, T., Hori, T., Ohgaki, K., & Tobe, T. (1993). The therapeutic effect of OK-432-combined adoptive immunotherapy against liver metastases from gastric or colorectal cancers. Biotherapy. https://doi.org/10.1007/bf01877385
Vancouver
Satoh K, Kan N, Okino T, Mise K, Yamasaki S, Harada T, et al. The therapeutic effect of OK-432-combined adoptive immunotherapy against liver metastases from gastric or colorectal cancers. Biotherapy. 1993. doi:10.1007/bf01877385
BibTeX
@article{Satoh1993,
author = {Satoh, K and Kan, N and Okino, T and Mise, K and Yamasaki, S and Harada, T and Hori, T and Ohgaki, K and Tobe, T},
title = {The therapeutic effect of OK-432-combined adoptive immunotherapy against liver metastases from gastric or colorectal cancers},
journal = {Biotherapy},
year = {1993},
doi = {10.1007/bf01877385}
}
EUVIMED